David Maloney is world expert in CAR-T therapy and was one of my doctors when I got my genetically modified cells in Seattle last year. Please enjoy their deeper dive into CAR-T from our conversation at EHA in Amsterdam. See: cllsociety.org/2019/11/eha-...
A recent post of mine spurred some controversy about the role of chemo-immunotherapy (CIT) in CLL. Dana Farber (DFCI) is one of the CLL Meccas that still sees a role for CIT, especially in combinations. In this interview with Dr. Davids of DFCI done at EHA 2019, he talks about adding ibrutinib to FCR to improve outcomes. See cllsociety.org/2019/11/eha-...
Stay strong. We are all in this together
Brian
CLLSociety.org